Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study

NCT00728910 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Atorvastatin
DRUG: ABT335
DRUG: ER Niacin

Sponsor

University of Pennsylvania

Collaborators

[object Object]